Combined sulphonylurea-biguanide therapy for non-insulin dependent diabetics. Metabolic effects of glibenclamide and metformin or phenformin in newly diagnosed obese patients

References

• Alberti K. G. M. M., Nattrass M. Lactic acidosis. Lancet 1977; 2: 25–291. Alberti K. G. M. M., Nattrass M. Lactic acidosis. Lancet 1977; 2: 25–29
   PubMed Web of Science ®Google Scholar
• Altschuld R. A., Kruger F. A. Inhibition of hepatic gluconeogenesis in guinea pig by phenformin. Ann. N. Y. Acad. Sci. 1968; 148: 612–6222. Altschuld R. A., Kruger F. A. Inhibition of hepatic gluconeogenesis in guinea pig by phenformin. Ann. N. Y. Acad. Sci. 1968; 148: 612–622
   PubMed Web of Science ®Google Scholar
• Butterfield W. J. H., Whichelow M. J. The hypoglycaemic action of phenformin: effect of phenformin on glucose metabolism in peripheral tissues. Diabetes 1962; 2: 281–2863. Butterfield W. J. H., Whichelow M. J. The hypoglycaemic action of phenformin: effect of phenformin on glucose metabolism in peripheral tissues. Diabetes 1962; 2: 281–286
   Google Scholar
• Caspary W. F., Creutzfeldt W. Analysis of inhibitory effect of biguanides on glucose absorption: inhibition of active sugar transport. Diabetologia 1971; 7: 379–3854. Caspary W. F., Creutzfeldt W. Analysis of inhibitory effect of biguanides on glucose absorption: inhibition of active sugar transport. Diabetologia 1971; 7: 379–385
   PubMed Web of Science ®Google Scholar
• Czyzyk A., Tawechi J., Sadowski J., Ponikowska I., Szezepanik Z. Effect of biguanides on intestinal absorption of glucose. Diabetes 1968; 17: 492–4985. Czyzyk A., Tawechi J., Sadowski J., Ponikowska I., Szezepanik Z. Effect of biguanides on intestinal absorption of glucose. Diabetes 1968; 17: 492–498
   PubMed Web of Science ®Google Scholar
• Fulop M., Hoberman H. D., Rascoff J. H., Bonheim N. A., Dreyer N. P., Tannenbaum H. Lactic acidosis in diabetic patients. Arch. Intern. Med. 1976; 136: 987–9906. Fulop M., Hoberman H. D., Rascoff J. H., Bonheim N. A., Dreyer N. P., Tannenbaum H. Lactic acidosis in diabetic patients. Arch. Intern. Med. 1976; 136: 987–990
   PubMed Web of Science ®Google Scholar
• Haeckel R., Haeckel H. Inhibition of gluconeogenesis from lactate by phenethylbiguanide in the perfused guinea pig liver. Diabetologia 1972; 8: 117–1247. Haeckel R., Haeckel H. Inhibition of gluconeogenesis from lactate by phenethylbiguanide in the perfused guinea pig liver. Diabetologia 1972; 8: 117–124
   PubMed Web of Science ®Google Scholar
• Isnard R., Lavieuville M. Acidose lactique et biguanides. Etat actuel de la question en France. J. Ann. Diabet. Hotel Dieu 1977; 18: 362–3758. Isnard R., Lavieuville M. Acidose lactique et biguanides. Etat actuel de la question en France. J. Ann. Diabet. Hotel Dieu 1977; 18: 362–375
   Google Scholar
• Kreisberg R. A. Glucose metabolism in normal and obese subjects. Effect of phenformin. Diabetes 1968; 17: 481–4889. Kreisberg R. A. Glucose metabolism in normal and obese subjects. Effect of phenformin. Diabetes 1968; 17: 481–488
   PubMed Web of Science ®Google Scholar
• Luft D., Schmulling R. M., Eggstein M. Lactic acidosis in biguanides treated diabetics. A review of 330 cases. Diabetologia 1978; 14: 75–8710. Luft D., Schmulling R. M., Eggstein M. Lactic acidosis in biguanides treated diabetics. A review of 330 cases. Diabetologia 1978; 14: 75–87
   PubMed Web of Science ®Google Scholar
• Marquié G. Effect of metformin on lipid metabolism in the rabbit aortic wall. Atherosclerosis 1978; 30: 165–17511. Marquié G. Effect of metformin on lipid metabolism in the rabbit aortic wall. Atherosclerosis 1978; 30: 165–175
   PubMed Web of Science ®Google Scholar
• Meyer R., Ipaktchi M., Clauser H. Specific inhibition of gluconeogenesis by biguanides. Nature 1967; 14: 203–20412. Meyer R., Ipaktchi M., Clauser H. Specific inhibition of gluconeogenesis by biguanides. Nature 1967; 14: 203–204
   Web of Science ®Google Scholar
• Nattrass M., Hinks L., Smythe P., Todd P. G., Alberti K. G. M. M. Metabolic effects of combined sulphonylurea and metformin therapy in maturity‐onset diabetics. Horm. Metab. Res. 1979; 11: 332–33713. Nattrass M., Hinks L., Smythe P., Todd P. G., Alberti K. G. M. M. Metabolic effects of combined sulphonylurea and metformin therapy in maturity‐onset diabetics. Horm. Metab. Res. 1979; 11: 332–337
   PubMed Web of Science ®Google Scholar
• Nattrass M., Todd P. G., Hinks L., Lloyd B., Alberti K. G. M. M. Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity‐onset diabetics. Diabetologia 1977; 13: 145–15214. Nattrass M., Todd P. G., Hinks L., Lloyd B., Alberti K. G. M. M. Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity‐onset diabetics. Diabetologia 1977; 13: 145–152
   PubMed Web of Science ®Google Scholar
• Searle G. L., Schilling S., Porte D., Barbaccia J., DeGrazia J., Cavallieri R. R. Body glucose kinetics in non diabetic human subjects after phenethylbiguanide. Diabetes 1966; 15: 173–17815. Searle G. L., Schilling S., Porte D., Barbaccia J., DeGrazia J., Cavallieri R. R. Body glucose kinetics in non diabetic human subjects after phenethylbiguanide. Diabetes 1966; 15: 173–178
   PubMed Web of Science ®Google Scholar
• Sirtori C. R., Weber G., Losi M., Shore B., Shore V., Ghiselli G. C., Tremoli E., Sirtori M., Paoletti R. Metformin and lipid metabolism. Res. Clin. Forums 1979; 1: 117–12216. Sirtori C. R., Weber G., Losi M., Shore B., Shore V., Ghiselli G. C., Tremoli E., Sirtori M., Paoletti R. Metformin and lipid metabolism. Res. Clin. Forums 1979; 1: 117–122
   Google Scholar
• Steiner D. P., Williams R. H. Action of phenethylbiguanide and related compounds. Diabetes 1959; 8: 154–15717. Steiner D. P., Williams R. H. Action of phenethylbiguanide and related compounds. Diabetes 1959; 8: 154–157
   PubMed Web of Science ®Google Scholar
• Waters A. K., Morgan D. B., Wales J. K. Blood lactate and pyruvate levels in diabetic patients treated with biguanides with and without sulphonylureas. Diabetologia 1978; 14: 95–9818. Waters A. K., Morgan D. B., Wales J. K. Blood lactate and pyruvate levels in diabetic patients treated with biguanides with and without sulphonylureas. Diabetologia 1978; 14: 95–98
   PubMed Web of Science ®Google Scholar
• Whichelow M. J., Butterfield W. J. H. In‐vivo studies on the hypoglycaemic action of phenformin. Postgrad. Med. J. 1969; 45: 24–29, Suppl.19. Whichelow M. J., Butterfield W. J. H. In‐vivo studies on the hypoglycaemic action of phenformin. Postgrad. Med. J. 1969; 45: 24–29, Suppl.
   PubMedGoogle Scholar
• Wildenhoff K. E. The influence of diabetic regulation on the diurnal variation in blood and urinary excretion of ketone bodies. Acta Med. Scand. 1975; 198: 127–13320. Wildenhoff K. E. The influence of diabetic regulation on the diurnal variation in blood and urinary excretion of ketone bodies. Acta Med. Scand. 1975; 198: 127–133
   PubMed Web of Science ®Google Scholar